What This Document Is
This is a 2021 pocket guide summarizing the Centers for Disease Control and Prevention (CDC) treatment guidelines for common Sexually Transmitted Infections (STIs). It’s designed as a quick reference for healthcare providers managing patients with suspected or confirmed STIs. The guide focuses on recommended and alternative treatment regimens for a range of infections.
Why This Document Matters
This resource is essential for clinicians – including those in OB/Maternity settings – who need readily available, evidence-based information on STI diagnosis and treatment. Accurate and up-to-date treatment is crucial for patient health, preventing complications, and controlling the spread of STIs. It’s particularly valuable in fast-paced clinical environments where immediate access to comprehensive guidelines isn’t always feasible. This guide supports informed decision-making regarding appropriate therapies and partner management strategies.
Common Limitations or Challenges
This pocket guide is *not* a comprehensive textbook on STIs. It provides treatment recommendations but does not cover detailed diagnostic procedures, epidemiological data, or preventative strategies beyond treatment. Users will still need to consult the full CDC guidelines for complete information and nuanced cases. It also doesn’t replace clinical judgment or consideration of individual patient factors.
What This Document Provides
This guide includes concise treatment recommendations for: Bacterial Vaginosis, Cervicitis, Chlamydial Infections, Epididymitis, Genital Herpes Simplex, Genital Warts (Human Papillomavirus), Gonococcal Infections, Lymphogranuloma Venereum, Nongonococcal Urethritis, Pediculosis Pubis, Pelvic Inflammatory Disease, Scabies, Syphilis, and Trichomoniasis. For each infection, it outlines recommended regimens and alternatives, categorized by risk factors (e.g., pregnancy). This preview shows examples for Bacterial Vaginosis and Chlamydial Infections. The full document provides this level of detail for *all* listed STIs, along with important footnotes regarding drug interactions and considerations. It *does not* include detailed information on STI prevention, testing protocols, or public health reporting requirements.